Ephedrae herba, a component of Japanese herbal medicine Mao-to, efficiently activates the replication of latent human immunodeficiency virus type 1 (HIV-1) in a monocytic cell line

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 12, 2008, Pages 2334-2337

  Murakami, Toru ^a   Harada, Hideki ^a,b   Suico, Mary Ann ^a   Shuto, Tsuyoshi ^a   Suzu, Shinya ^a   Kai, Hirofumi ^a   Okada, Seiji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Ephedrae herba; Human immunodeficiency virus type 1; Japanese herbal medicine; Latent infection; Mao to; Nuclear factor kappa B

Indexed keywords

ANTIRETROVIRUS AGENT; BU ZHONG YI QI TANG; EPHEDRA EXTRACT; HERBACEOUS AGENT; HOTYU EKKI TO; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAMPO; LUCIFERASE; MAO TO; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; REN SHEN YANG RONG TANG; SHI QUAN DA BU TANG; TJ 108; TJ 27; UNCLASSIFIED DRUG; XIAO CHAI HU TANG;

ARTICLE; CELL CLONE; CELL STRAIN U937; CONTROLLED STUDY; ENZYME ASSAY; EPHEDRA; FLOW CYTOMETRY; GLYCYRRHIZA; HELA CELL; HERBAL MEDICINE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPAN; MEDICINAL PLANT; NONHUMAN; PERSISTENT VIRUS INFECTION; POWDER; TRADITIONAL MEDICINE; VIRUS REPLICATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; DRUGS, CHINESE HERBAL; EPHEDRA; FLOW CYTOMETRY; HIV-1; HUMANS; LUCIFERASES; MONOCYTES; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 57349142006     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.2334     Document Type: Article

References (37)

1. Fauci A. S., Science, 239, 617-622 (1988).
2. Peterson S., Reid A. P., Kim S., Siliciano R. F., Adv. Pharmacol., 55, 411-425 (2007).
3. Finzi D., Hermankova M., Pierson T., Carruth L. M., Buck C., Chaisson R. E., Quinn T. C., Chadwick K., Margolick J., Brookmeyer R., Gallant J., Markowitz M., Ho D. D., Richman D. D., Siliciano R. F., Science, 278, 1295-1300 (1997).
4. Gulick R. M., Mellors J. W., Havlir D., Eron J. J., Gonzalez C., McMahon D., Richman D. D., Valentine F. T., Jonas L., Meibohm A., Emini E. A., Chodakewitz J. A., N. Engl. J. Med., 337, 734-739 (1997).
5. Hammer S. M., Squires K. E., Hughes M. D., Grimes J. M., Demeter L. M., Currier J. S., Eron J. J., Feinberg J. E., Balfour H. H., Deyton L. R., Chodakewitz J. A., Fischl M. A., Phair J. P., Pedneault L., Nguyen B.-Y., Cook J. C., The AIDS Clinical Trials Group 320 Study Team, N. Engl. J. Med., 337, 725-733 (1997).
6. Wong J. K., Hezareh M., Gunthard H. F., Havlir D. V., Ignacio C. C., Spina C. A., Richman D. D., Science, 278, 1291-1295 (1997).
7. Finzi D., Blankson J., Siliciano J. D., Margolick J. B., Chadwick K., Pierson T., Smith K., Lisziewicz J., Lori F., Flexner C., Quinn T. C., Chaisson R. E., Rosenberg E., Walker B., Gange S., Gallant J., Siliciano R. F., Nat. Med., 5, 512-517 (1999).
8. Siliciano J. D., Siliciano R. F., J. Antimicrob. Chemother., 54, 6-9 (2004).
9. Bailey J., Blankson J. N., Wind-Rotolo M., Siliciano R. F., Curr. Opin. Immunol., 16, 470-476 (2004).
10. Williams S. A., Greene W. C., Trends Microbiol., 13, 137-139 (2005).
11. Bukrinsky M. I., Haffar O. K., Front Biosci., 4, D772-D781 (1999).
12. Folks T. M., Justement J., Kinter A., Dinarello C. A., Fauci A. S., Science, 238, 800-802 (1987).
13. Folks T. M., Justement J., Kinter A., Schnittman S., Orenstein J., Poli G., Fauci A. S., J. Immunol., 140, 1117-1122 (1988).
14. Duh E. J., Maury W. J., Folks T. M., Fauci A. S., Rabson A. B., Proc. Natl. Acad. Sci. U.S.A., 86, 5974-5978 (1989).
15. Osborn L., Kunkel S., Nabel G. J., Proc. Natl. Acad. Sci. U.S.A., 86, 2336-2340 (1989).
16. Poli G., Bressler P., Kinter A., Duh E., Timmer W. C., Rabson A., Justement J. S., Stanley S., Fauci A. S., J. Exp. Med., 172, 151-158 (1990).
17. Yu F., Takahashi T., Moriya J., Kawaura K., Yamakawa J., Kusaka K., Itoh T., Morimoto S., Yamaguchi N., Kanda T., J. Int. Med. Res., 34, 231-239 (2006).
18. Kubo T., Nishimura H., Phytomedicine, 14, 96-101 (2007).
19. Harada H., Goto Y., Ohno T., Suzu S., Okada S., Eur. J. Immunol., 37, 2148-2155 (2007).
20. Schreiber E., Matthias P., Muller M. M., Schaffner W., Nucleic Acids Res., 17, 6419 (1989).
21. Oba M., Yano S., Shuto T., Suico M. A., Eguma A., Kai H., Int. J. Oncol., 32, 1317-1324 (2008).
22. Borchers A. T., Sakai S., Henderson G. L., Harkey M. R., Keen C. L., Stern J. S., Terasawa K., Gershwin M. E., J. Ethnopharmacol., 73, 1-13 (2000).
23. Nabel G., Baltimore D., Nature (London), 326, 711-713 (1987).
24. Raziuddin Mikovits J. A., Calvert I., Ghosh S., Kung H. F., Ruscetti F. W., Proc. Natl. Acad. Sci. U.S.A., 88, 9426-9430 (1991).
25. Baeuerle P. A., Baltimore D., Genes Dev., 3, 1689-1698 (1989).
26. Baeuerle P. A., Baltimore D., Science, 242, 540-546 (1988).
27. Siliciano R. F., Top HIV Med., 13, 96-100 (2005).
28. Chun T. W., Stuyver L., Mizell S. B., Ehler L. A., Mican J. A., Baseler M., Lloyd A. L., Nowak M. A., Fauci A. S., Proc. Natl. Acad. Sci. U.S.A., 94, 13193-13197 (1997).
29. Chun T. W., Engel D., Mizell S. B., Ehler L. A., Fauci A. S., J. Exp. Med., 188, 83-91 (1998).
30. Kulkosky J., Culnan D. M., Roman J., Dornadula G., Schnell M., Boyd M. R., Pomerantz R. J., Blood, 98, 3006-3015 (2001).
31. Biancotto A., Grivel J. C., Gondois-Rey F., Bettendroffer L., Vigne R., Brown S., Margolis L. B., Hirsch I., J. Virol., 78, 10507-10515 (2004).
32. Oguariri R. M., Brann T. W., Imamichi T., J. Biol. Chem., 282, 3594-3604 (2007).
33. Ikegami F., Fujii Y., Satoh T., Toxicology, 198, 221-228 (2004).
34. Kim S. C., Byun S. H., Yang C. H., Kim C. Y., Kim J. W., Kim S. G., Toxicology, 197, 239-251 (2004).
35. Kim T., Zhao R., Park S., Lee R., Cho I., Yang C., Kim S. G., Kim S. C., Br. J. Pharmacol., 154, 165-173 (2008).
36. Cherng J.-M., Lin H.-J., Hsu Y.-H., Hung M.-S., Lin J.-C., Antiviral Res., 62, 27-36 (2004).
37. Karin M., Greten F. R., Nat. Rev. Immunol., 5, 749-759 (2005).